Connections Alnylam Pharmaceuticals, Inc.

ALNY

US02043Q1076

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 16/01/2026 GMT			5-day change	1st Jan Change
359.27 ^USD	+0.00%		-3.14%	-9.65%

01-14	Alnylam Pharmaceuticals Insider Sold Shares Worth $1,395,992, According to a Recent SEC Filing	MT
01-14	Alnylam Pharmaceuticals Insider Sold Shares Worth $547,927, According to a Recent SEC Filing	MT

48

Listed companies

21

Private companies

141

Insiders

Relation chart of related listed companies: Alnylam Pharmaceuticals, Inc.

Active Relations

Past Relations

Related listed companies: Alnylam Pharmaceuticals, Inc.

BIOCRYST PHARMACEUTICALS, INC.

Theresa Heggie

MYRIAD GENETICS, INC.

Colleen Reitan

ATYR PHARMA, INC.

Paul Schimmel

APELLIS PHARMACEUTICALS, INC.

Kelley Boucher

RHYTHM PHARMACEUTICALS, INC.

Stuart Arbuckle

ATEA PHARMACEUTICALS, INC.

Keith Pietropaolo

SPYRE THERAPEUTICS, INC.

Joshua Friedman

SQZ BIOTECHNOLOGIES COMPANY

PULSE BIOSCIENCES, INC.

Manmeet Singh Soni

OVID THERAPEUTICS INC.

Kevin Fitzgerald

TAKEDA PHARMACEUTICAL COMPANY LIMITED

John Maraganore

ELEVANCE HEALTH, INC.

KARYOPHARM THERAPEUTICS INC.

Barry Greene

UNIQURE N.V.

Erin Boyer

SERES THERAPEUTICS, INC.

Dennis Ausiello

IMMUNEERING CORPORATION

Laurie Keating

PROQR THERAPEUTICS N.V.

Theresa Heggie

INTELLIA THERAPEUTICS, INC.

PLIANT THERAPEUTICS, INC.

David Pyott

PRAXIS PRECISION MEDICINES, INC.

Stuart Arbuckle

KALVISTA PHARMACEUTICALS, INC.

Laurence Reid

VIR BIOTECHNOLOGY, INC.

Charles Sigal

Vicki Sato

SUMMIT THERAPEUTICS INC.

Manmeet Singh Soni

KYMERA THERAPEUTICS, INC.

John Maraganore

Jared Gollob

SCHOLAR ROCK HOLDING CORPORATION

Akshay Vaishnaw

Jing Marantz

ALLOGENE THERAPEUTICS, INC.

Vicki Sato

AUTOLUS THERAPEUTICS PLC

John Berriman

Michael Bonney

BEAM THERAPEUTICS INC.

ARCTURUS THERAPEUTICS HOLDINGS INC.

Jing Marantz

TAYSHA GENE THERAPIES, INC.

Laura Sepp-Lorenzino

INVIVYD, INC.

Christine Lindenboom

SIONNA THERAPEUTICS, INC.

LEXEO THERAPEUTICS, INC.

Tolga Tanguler

CENTESSA PHARMACEUTICALS PLC

Karen Anderson

RANI THERAPEUTICS HOLDINGS, INC.

RAPPORT THERAPEUTICS, INC.

Steven Paul

John Maraganore

FORTREA HOLDINGS INC.

Agnieszka Gallagher

CERVOMED INC.

Jeffrey Poulton

DIANTHUS THERAPEUTICS, INC.

Robert McGarr

Active Relations

Past Relations

Relationship chart for related private companies: Alnylam Pharmaceuticals, Inc.

Active Relations

Past Relations

Related private companies: Alnylam Pharmaceuticals, Inc.

ARCH Venture Partners LLC

Investment Managers

Vicki Sato

John Maraganore

Biotechnology Innovation Organization

Miscellaneous Commercial Services

KinDex Pharmaceuticals, Inc.

Paul Schimmel

Dennis Ausiello

CHP Management, Inc.

Investment Managers

Paul Schimmel

John Clarke

Atlas Venture Advisors, Inc.

Investment Managers

John Maraganore

Jason Rhodes

Akshay Vaishnaw

Massachusetts Institute of Technology

Finance/Rental/Leasing

Phillip Sharp

Ed Scolnick

The Royal Society

Investment Trusts/Mutual Funds

Phillip Sharp

Carolyn Bertozzi

National Academy of Sciences

Miscellaneous Commercial Services

American Academy of Arts & Sciences

Miscellaneous Commercial Services

National Academy of Medicine (United States)

Miscellaneous Commercial Services

American Philosophical Society

Miscellaneous Commercial Services

Paul Schimmel

Phillip Sharp

Foundation for the National Institutes of Health, Inc.

Miscellaneous Commercial Services

Steven Paul

Margaret Hamburg

BIOTECanada

Biotechnology

Colleen Coxson

Jeff Miller

Harvard Medical School

Other Consumer Services

Dennis Ausiello

Yvonne Greenstreet

Longwood Fund Management LLC

Investment Managers

Atlas Venture Life Science Advisors LLC

Alnylam UK Ltd.

National Academy of Inventors

Paul Schimmel

Carolyn Bertozzi

Dewpoint Therapeutics, Inc.

Hemab ApS

Nucleate Bio, Inc.

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Miscellaneous Commercial Services	6
Investment Managers	5
Pharmaceuticals: Major	4
Other Consumer Services	1
Biotechnology	1
Investment Trusts/Mutual Funds	1
Finance/Rental/Leasing	1
Managed Health Care	1
Medical Specialties	1

Countries of related companies

United States	58
United Kingdom	4
Netherlands	2
Switzerland	2
Denmark	1
Canada	1
Japan	1

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in discovering, developing, manufacturing and commercializing novel therapeutics based on ribonucleic acid interference (RNAi). Its marketed products include AMVUTTRA (vutrisiran) for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR) with polyneuropathy in adults; ONPATTRO (patisiran) for the treatment of the polyneuropathy of hATTR amyloidosis in adults; GIVLAARI (givosiran) for the treatment of adults with acute hepatic porphyria; OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1, and Leqvio (inclisiran), which is being developed and commercialized by its partner, Novartis AG, for the treatment of adults with hypercholesterolemia or mixed dyslipidemia. In addition, the Company develops Cemdisiran to treat complement-mediated diseases, Belcesiran for the treatment of alpha-1 liver disease, Elebsiran, Zilebesiran, ALN-APP, ALN-HSD, Fitusiran, and others.

Employees

2,230

Sector

Pharmaceuticals

Calendar

02-11 - Q4 2025 Earnings Release (Projected)

More about the company

Connections Alnylam Pharmaceuticals, Inc.

Equities

ALNY

US02043Q1076

Pharmaceuticals

48

21

141

Relation chart of related listed companies: Alnylam Pharmaceuticals, Inc.

Related listed companies: Alnylam Pharmaceuticals, Inc.

Relationship chart for related private companies: Alnylam Pharmaceuticals, Inc.

Related private companies: Alnylam Pharmaceuticals, Inc.

Connection statistics

Activities of related companies

Countries of related companies

Company Profile